Broncus Holding Corporation (HKG:2216)
Hong Kong · Delayed Price · Currency is HKD 1.070
+0.020 (1.90%)
May 11, 2026, 3:59 PM HKT
Broncus Holding Revenue
In the year 2025, Broncus Holding had annual revenue of $174.00K USD, down -97.86%. Broncus Holding had revenue of $-1.48M in the half year ending December 31, 2025.
Revenue
$174.00K
Revenue Growth
-97.86%
P/S Ratio
416.43
Revenue / Employee
$910.99
Employees
191
Market Cap
563.97M HKD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 174.00K | -7.96M | -97.86% |
| Dec 31, 2024 | 8.13M | -2.12M | -20.71% |
| Dec 31, 2023 | 10.26M | 842.00K | 8.95% |
| Dec 31, 2022 | 9.41M | -1.48M | -13.57% |
| Dec 31, 2021 | 10.89M | 7.63M | 234.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sisram Medical | 2.84B |
| Austar Lifesciences | 1.70B |
| Yestar Healthcare Holdings Company | 1.66B |
| Gaush Meditech | 1.54B |
| Vincent Medical Holdings | 932.78M |
| Acotec Scientific Holdings | 717.35M |
| Shanghai HeartCare Medical Technology Corporation | 454.34M |
| Venus Medtech (Hangzhou) | 341.39M |